Top 5 China Stocks To Own For 2019

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-1044091206&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1044091206/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; U.S. Trade Rep. Robert Lighthizer&a;nbsp;has set March 2 as the date to begin imposing higher tariffs if Washington believes trade talks are going nowhere.&a;nbsp; If so, it would be a big blow to the market, and to President Trump&s;s call that a deal was in the works sooner rather than later. (Photo by Jim WATSON /AFP, Getty Images)

The 90-day trade war truce ends March 2. That&s;s the day U.S. Trade Representative Robert Lighthizer gave to increase tariffs on a number of Chinese imports if there is no progress in trade talks this month. Presidents Trump and Xi Jinping are supposed to meet in Asia over the next four weeks, possibly putting that date on hold. No date or location has been set.

Last week&s;s meeting between trade negotiators saw little progress on important issues like intellectual property protections, the biggest sticking point in a deal. China continues to open its market to foreign firms, with all-important financial services continuing to open up in mainland China. JP Morgan co-president Daniel Pinto said the firm is on track to open an investment bank in China this year and acquire a greater stake in a Chinese wealth&a;nbsp;management firm it has been partnered up with for the last few years.

Top 5 China Stocks To Own For 2019: Baidu Inc.(BIDU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Baidu (NASDAQ:BIDU) was downgraded by research analysts at Credit Suisse Group from an “outperform” rating to a “neutral” rating in a research note issued on Friday.

  • [By Chris Hill]

    In this Motley Fool Money podcast, host Chris Hill and senior Motley Fool analysts Jason Moser, Matt Argersinger, and Ron Gross dig into some of the week’s more interesting news out of Wall Street, and while they can’t help but lead off with the massive milestone passed by Apple (NASDAQ:AAPL), there was plenty more to talk about. Baidu (NASDAQ:BIDU) is being troubled by the worrisome rumor that Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG) is heading back to China. TripAdvisor (NASDAQ:TRIP) is paying for the failure of its instant-booking feature to pay off.

  • [By ]

    In the Lightning Round, Cramer was bullish on Walgreens Boots Alliance (WBA) , Arena Pharmaceuticals (ARNA) , Dominion Energy (D) , Idexx Laboratories (IDXX) , GlaxoSmithKline (GSK) , Baidu.com (BIDU) , Baozun (BZUN) and Alibaba (BABA) .

  • [By ]

    Alibaba began quietly testing autonomous driving technologies last year, led by Wang Gang, the chief scientist of Alibaba’s A.I. Labs. Despite its late start, Alibaba appears to be moving quickly. Although it will be playing catch up to Baidu (BIDU) and Tencent (TCEHY) , which already have approval from Chinese regulators for open-road testing.

  • [By Chris Hill]

    Hill: We’ll stick with video for a minute or two longer. Now that iQiyi is public — you’ve talked about this before, is this of interest to you? Is this a stock you’ve already bought, or it’s on the watch list? And for those who don’t know, iQiyi was essentially spun out of Baidu (NASDAQ:BIDU). So, the Google of China spins out the Netflix of China. And as you said before, it seems like, if nothing else, it’s a win for Baidu shareholders, because Baidu still has the ownership stake.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Top 5 China Stocks To Own For 2019: Top Image Systems Ltd.(TISA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Top Image Systems (TISA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Top Image Systems (TISA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 China Stocks To Own For 2019: Renesola Ltd.(SOL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media headlines that may have impacted Accern’s scoring:

    Get ReneSola alerts:

    ReneSola Sells North Carolina Solar Project To Greenbacker (solarindustrymag.com) ReneSola (SOL) Rating Increased to Neutral at Roth Capital (americanbankingnews.com) ReneSola (SOL) Q1 Earnings in Line, Revenues Top Estimates (zacks.com) ReneSola’s (SOL) CEO Xianshou Li on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) ReneSola (SOL) Releases Earnings Results (americanbankingnews.com)

    Shares of ReneSola traded up $0.08, hitting $2.76, during trading on Friday, Marketbeat.com reports. The stock had a trading volume of 124,969 shares, compared to its average volume of 108,565. The firm has a market capitalization of $102.11 million, a PE ratio of 21.23 and a beta of 2.05. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.36. ReneSola has a 12 month low of $2.12 and a 12 month high of $3.79.

  • [By Max Byerly]

    Sola Token (CURRENCY:SOL) traded up 26.7% against the US dollar during the 24 hour period ending at 22:00 PM E.T. on September 28th. One Sola Token token can currently be bought for $0.0085 or 0.00000131 BTC on popular exchanges including Tidex and OpenLedger DEX. Sola Token has a market capitalization of $0.00 and approximately $3,239.00 worth of Sola Token was traded on exchanges in the last 24 hours. During the last week, Sola Token has traded flat against the US dollar.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on ReneSola (SOL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Sola Token (CURRENCY:SOL) traded 17.9% lower against the dollar during the 1-day period ending at 16:00 PM E.T. on October 11th. One Sola Token token can now be bought for about $0.0054 or 0.00000087 BTC on cryptocurrency exchanges including Tidex and OpenLedger DEX. Sola Token has a total market cap of $153,306.00 and $1,856.00 worth of Sola Token was traded on exchanges in the last 24 hours. In the last seven days, Sola Token has traded down 12.2% against the dollar.

Top 5 China Stocks To Own For 2019: ATA Inc.(ATAI)

Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top 5 China Stocks To Own For 2019: Clean Diesel Technologies Inc.(CDTI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

    Get Molecular Templates alerts:

    Trading Center: Watching the Levels for Molecular Templates, Inc. (:MTEM): Move of 0.02 Since the Open (stocknewscaller.com) Molecular Templates (MTEM) Announces Clinical Data at 2018 ASCO Meeting (streetinsider.com) Gallbladder Cancer Treatment Sales Market Size by Players, Regions, Type, Application and Forecast to 2025 (exclusivereportage.com) ATR in spotlight EnSync, Inc. (NYSE:ESNC), CDTi Advanced Materials, Inc. (NASDAQ:CDTI), Molecular Templates, Inc … (stocksnewspoint.com)

    MTEM has been the subject of several research analyst reports. ValuEngine lowered shares of Molecular Templates from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Zacks Investment Research raised shares of Molecular Templates from a “sell” rating to a “hold” rating in a research report on Thursday, June 7th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $5.20.

  • [By Logan Wallace]

    Shares of CDTi Advanced Materials Inc (NASDAQ:CDTI) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $0.33 and last traded at $0.36, with a volume of 500 shares trading hands. The stock had previously closed at $0.36.

Leave a Reply

Your email address will not be published. Required fields are marked *